UP!

OCLS $4.95

OCLS target price
4.95
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-04-20 Reiterated Rating Maxim Group Buy $3.00
2016-03-07 Reiterated Rating Maxim Group Buy $3.00
2015-09-24 Reiterated Rating Maxim Group Buy $3.00
2015-06-26 Initiated Coverage Maxim Group Buy $3.00
2014-06-13 Downgrade Sidoti Buy to Neutral
2010-12-14 Initiated Rodman & Renshaw Mkt Outperform $3
2009-08-18 Initiated Dawson James Buy $4.50
2008-11-07 Downgrade Rodman & Renshaw Mkt Outperform to Mkt Perform
2008-08-06 Reiterated Rodman & Renshaw Mkt Outperform $14 to $12
2008-04-11 Reiterated Rodman & Renshaw Mkt Outperform $16 to $14
2007-07-18 Reiterated Rodman & Renshaw Mkt Outperform $13 to $16
2007-06-21 Initiated Rodman & Renshaw Mkt Outperform $13
2007-03-27 Initiated Roth Capital Buy $10
1970-01-01
2016-04-20 Reiterated Rating Maxim Group Buy $3.00
2016-03-07 Reiterated Rating Maxim Group Buy $3.00
2015-09-24 Reiterated Rating Maxim Group Buy $3.00
2015-06-26 Initiated Coverage Maxim Group Buy $3.00
2014-06-13 Downgrade Sidoti Buy to Neutral

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In OCLS 1 funds of 2213 total. Show all

Fund name Ticker shares
NEW ENGLAND SECURITIES CORP /MA/ 442

Major Shareholders

Name Relationship Total Shares Holding stocks
Burlingame Robert 15.28%  (1294931) OCLS /
Alimi Hojabr Chief Executive Officer 12.17%  (1031050) OCLS / RTGN /
Conley Richard K 1.45%  (122650) OCLS / RTGN /
French Gregory M 0.62%  (52760) OCLS / RTGN /
Birnbaum Jay E 0.60%  (50607) OCLS /
MCLAUGHLIN JOHN 0.55%  (46947) OCLS /
Harrison Russell Joseph 0.53%  (44982) OCLS /
BARBARI SHARON SURREY 0.51%  (43417) CYTK / OCLS /
Schutz James J Vice President 0.42%  (35858) OCLS /
Miller Robert E Chief Financial Officer 0.22%  (18868) OCLS /
Northey Robert Allen Exec. VP of Res & Development 0.10%  (8082) OCLS /
Umscheid Marc Chief Strategy/Mkt Officer 0.04%  (3392) OCLS /